Case report: Pembrolizumab as an alternative to atezolizumab following a severe infusion reaction

The emergence of immune-checkpoint inhibitors (ICIs) has revolutionized the field of oncology, providing promising results in various malignancies. However, ICIs can sometimes lead to severe injection reactions, requiring alternative treatment options. In this case report, we introduce a case of a s...

Full description

Bibliographic Details

Main Authors:	Seung Hyuk Lee, Hyeon Jong Kim, Hyun Jin Bang, Su Ji Park, Ji Eun Yu, Seung Woo Jeong, Woo Kyun Bae
Format:	Artigo
Language:	Inglês
Published:	Frontiers Media S.A. 2024-03-01
Series:	Frontiers in Oncology
Subjects:	immune-checkpoint inhibitors (ICIs) atezolizumab pembrolizumab infusion reaction hypersensitivity immune-related adverse drug reactions (ADRs)
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2024.1273043/full
Tags:	Add Tag No Tags, Be the first to tag this record!